Circulating Proprotein Convertase Subtilisin/Kexin Type 9 Levels and Cardiometabolic Risk Factors: A Population-Based Cohort Study

Frontiers in Cardiovascular Medicine

Guang Ning¹  Hongmei Zhang²  Weiwei Zhang²  Zhen Yang²  Yixin Niu²  Li Qin²  Qing Su²  Jie Shi²  Ning Lin²  Xiaoyong Li²  Jiangao Fan³ 

[1] Department of Endocrine and Metabolic Diseases, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Institute of Endocrinology and Metabolism, Shanghai Jiao Tong University School of Medicine, Shanghai, China;Department of Endocrinology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China;Shanghai Key Laboratory of Children's Digestion and Nutrition, Department of Gastroenterology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China;

关键词: proprotein convertase subtilisin kexin type 9;    dyslipidemia;    hypertension;    type 2 diabetes;    metabolic syndrome;    cardiometabolic risk factors;   

DOI  :  10.3389/fcvm.2021.664583

来源: Frontiers

【 授权许可】

CC BY